People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fountain Therapeutics, Inc. | — | Biotechnology | Series B | $26.9M | $348.5M | 2018 |
Thomas A. Rando at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas A. Rando on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alex Morgan | 1 | 10 |
| William Greene | 1 | 6 |
| Ashish Khanna | 1 | 3 |
| Thomas Rando | 1 | 1 |
| John Dimos | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.